The Infectious Disease Society of America (IDSA) just published a guideline on the use of seasonal vaccines in immunocompromised patients. The guideline, Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients, addresses specific patients populations including patients who are recipients of solid organ transplants, patients who have an autoimmune disease treated with immunosuppressants or biologics, and more.
Today, we’re showcasing the recommendations regarding COVID-19, influenza, and RSV vaccines for immunocompromised patients that are included in the 2026 IDSA guideline. View the full-text version to view the recommendation grading as well as associated evidence summaries and rationale.
Recommendations from the 2026 IDSA Guideline on Seasonal Vaccines for Immunocompromised Patients
COVID-19 Recommendation
- In adults and children with compromised immunity*, the IDSA guideline panel recommends administering age-appropriate 2026-2027 COVID-19 vaccinations.
Influenza Recommendation
- In adults and children with compromised immunity*, the IDSA guideline panel recommends administering age-appropriate 2026-2027 influenza vaccinations.
RSV Recommendation
- In adults and adolescents with compromised immunity*, the IDSA guideline panel recommends administering RSV vaccinations.
Check out our other infectious diseases content and be sure to sign up for alerts to stay informed on the latest published guidelines and articles.